📷 Image: Wikimedia Commons / The U.S. Food and Drug Administration
Entertainment
India Story Team Meets FDA Commissioner Tukaram Mundhe Ahead of Film Release
✍️ Koimoi
🗓 22 Jul 2026, 06:02 AM
👁 1
The India Story Team met with FDA Commissioner Tukaram Mundhe to discuss compliance matters before the upcoming release of their film.
The India Story Team convened with FDA Commissioner Tukaram Mundhe in a meeting held in Mumbai to review the film’s compliance with the Food and Drug Administration’s regulations.
During the session, the team presented the film’s content and highlighted the safety protocols followed during production. Commissioner Mundhe emphasized the importance of adhering to the agency’s guidelines, particularly concerning any depictions of food, medicine, or health‑related content.
The discussion also covered the timeline for the film’s release, with both parties agreeing on a schedule that would allow for any necessary adjustments before the public premiere.
Commissioner Mundhe assured the team that the FDA would provide a clear assessment once the final cut is submitted. The meeting is seen as a standard step for productions that involve sensitive health or safety themes.
The India Story Team expressed confidence that the film would meet all regulatory requirements and look forward to a smooth release following the FDA’s review.
During the session, the team presented the film’s content and highlighted the safety protocols followed during production. Commissioner Mundhe emphasized the importance of adhering to the agency’s guidelines, particularly concerning any depictions of food, medicine, or health‑related content.
The discussion also covered the timeline for the film’s release, with both parties agreeing on a schedule that would allow for any necessary adjustments before the public premiere.
Commissioner Mundhe assured the team that the FDA would provide a clear assessment once the final cut is submitted. The meeting is seen as a standard step for productions that involve sensitive health or safety themes.
The India Story Team expressed confidence that the film would meet all regulatory requirements and look forward to a smooth release following the FDA’s review.